# FDA Warning Letter: Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre
> 2026-05-12 · Center for Drug Evaluation and Research (CDER) · `f07b933d52c8a587`
## Letter
- **Company:** Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre
- **Posted Date:** 2026-05-12
- **Letter Issue Date:** 2026-04-29
- **Issuing Office:** Center for Drug Evaluation and Research (CDER)
## Subject
In Vivo Bioavailability-Bioequivalence Studies – Clinical
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · MORVS · CC0 1.0*